9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 116

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Progression-free survival,  Overall survival,  Overall Response Rate,

Interventions: Nintedanib, Placebo

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Triple (Participant, Care Provider, Investigator),Primary Purpose: Treatment

Primary Completion Date: February 2019

Completion Date: October 2020

Last  Posted Date: August 14, 2018

Location: UZ Antwerpen, Antwerpen, Belgium

Website Link: https://ClinicalTrials.gov/show/NCT02863055

Was this article helpful?
Dislike 0